Company profile
Home
We are discovering and developing innovative medicines to preserve peoples sight and fight the devastating impact of blindness around the world.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
AP01 | Transaction MzQ0MTkxNTE3MWFkaXF6a2N4
Published 05 Nov 2024 06:45
TM01 | Transaction MzQ0MTkxNTExMmFkaXF6a2N4
Published 04 Nov 2024 04:02
AA | Transaction MzQzODU5NTMzN2FkaXF6a2N4 | Paper/PDF filed
Published 15 Oct 2024 06:26
PSC05 | Transaction MzQzNjIyMDMwNWFkaXF6a2N4
Published 17 Sep 2024 14:37
Company registered at Companies House
1 Nov 2018 to 31 Jan 2021
"The rapid development of Gene Therapy Medicinal Products (GTMPs) requires new manufacturing processes and facilities. Gyroscope Therapeutics Ltd and Freeline Therapeutics Ltd are UK-based SMEs developing gene therapies for different indications but which are both delivered via adeno-associated viral (AAV) vectors. Gyroscope and Freeline intend to co-deve...
